Karyn Heavner

Dr. Karyn Heavner


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2010 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
KHKaryn Heavner
Karyn Heavner
CPCarl Phillips
Carl Phillips
Igor BurstynIgor Burstyn
Igor Burstyn
WHWarren Hare
Warren Hare
Consumers of epidemiology may prefer to have one measure of risk arising from analysis of a 2-by-2 table. However, reporting a single measure of association, such as one odds ratio (OR) and 95% confidence interval, from a continuous exposure variable that was dichotomized withholds much potentially useful information. Results of this type of analysis are often reported for one such dichotomization, as if no other cutoffs were investigated or even possible.

2 July 2009 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
KHKaryn Heavner
Karyn Heavner
ZRZale Rosenberg
Zale Rosenberg
CPCarl Phillips
Carl Phillips
Despite the well-known risks of smoking, policy, social pressure, and accessible cessation programs, tens of millions of North American adults continue smoking rather than quitting or switching to less harmful non-combustion nicotine products. We surveyed people smoking in public in Edmonton, Canada (n = 242, year = 2007) to investigate smokers' reasons for resisting switching to low-risk nicotine sources. 43% had used low-risk products (mostly pharmaceutical nicotine). 75% indicated willingness to consider switching to low-risk products. Smokers cited similar reasons for not switching to smokeless tobacco and pharmaceutical nicotine, largely based on misinformation. Accurate risk information may lead many to try low-risk nicotine products.

CGCarol Ann Gross-Davis
Carol Ann Gross-Davis
KHKaryn Heavner
Karyn Heavner
AFArthur L Frank
Arthur L Frank
CNCraig Newschaffer
Craig Newschaffer
JKJudith Klotz
Judith Klotz
Igor BurstynIgor Burstyn
Igor Burstyn
Background: The etiology of myeloproliferative neoplasms (MPN) (polycythemia vera; essential thrombocythemia; primary myelofibrosis) is unknown, however they are associated with a somatic mutation—JAK2 V617F—suggesting a potential role for environmental mutagens. Methods: We conducted a population-based case-control study in three rural Pennsylvania counties of persons born 1921–1968 and residing in the area between 2000–2008. Twenty seven MPN cases and 292 controls were recruited through random digit dialing. Subjects were genotyped and odds ratios estimated for a select set of polymorphisms in environmentally sensitive genes that might implicate specific environmental mutagens if found to be associated with a disease. Results: The presence of NAT2 slow acetylator genotype, and CYP1A2, GSTA1, and GSTM3 variants were associated with an average 3–5 fold increased risk. Conclusions: Exposures, such as to aromatic compounds, whose toxicity is modified by genotypes associated with outcome in our analysis may play a role in the environmental etiology of MPNs.

KHKaryn Heavner
Karyn Heavner
Igor BurstynIgor Burstyn
Igor Burstyn
Variation in the odds ratio (OR) resulting from selection of cutoffs for categorizing continuous variables is rarely discussed. We present results for the effect of varying cutoffs used to categorize a mismeasured exposure in a simulated population in the context of autism spectrum disorders research. Simulated cohorts were created with three distinct exposure-outcome curves and three measurement error variances for the exposure. ORs were calculated using logistic regression for 61 cutoffs (mean ± 3 standard deviations) used to dichotomize the observed exposure. ORs were calculated for five categories with a wide range for the cutoffs. For each scenario and cutoff, the OR, sensitivity, and specificity were calculated. The three exposure-outcome relationships had distinctly shaped OR (versus cutoff) curves, but increasing measurement error obscured the shape. At extreme cutoffs, there was non-monotonic oscillation in the ORs that cannot be attributed to “small numbers.” Exposure misclassification following categorization of the mismeasured exposure was differential, as predicted by theory. Sensitivity was higher among cases and specificity among controls. Cutoffs chosen for categorizing continuous variables can have profound effects on study results. When measurement error is not too great, the shape of the OR curve may provide insight into the true shape of the exposure-disease relationship.

1 January 2010 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
KHKaryn Heavner
Karyn Heavner
ZRZale Rosenberg
Zale Rosenberg
FTFrancis Tenorio
Francis Tenorio
CPCarl Phillips
Carl Phillips
Tobacco retailers are potential public health partners for tobacco harm reduction (THR). THR is the substitution of highly reduced-risk nicotine products, such as smokeless tobacco (ST) or pharmaceutical nicotine, for cigarettes. The introduction of a Swedish-style ST product, du Maurier snus (dMS) (Imperial Tobacco Canada Limited), which was marketed as a THR product, provided a unique opportunity to assess retailers' knowledge. This study examined retailers' knowledge of THR and compliance with recommendations regarding tobacco sales to young adults.

16 April 2015 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
KHKaryn Heavner
Karyn Heavner
CGCarol Ann Gross‐Davis
Carol Ann Gross‐Davis
AFArthur L. Frank
Arthur L. Frank
CNCraig Newschaffer
Craig Newschaffer
JKJudith Klotz
Judith Klotz
Igor BurstynIgor Burstyn
Igor Burstyn